Search results
Rise of dark AI: Malicious LLMs like FraudGPT, WormGPT the new frontier of online threats! How can...
Business Insider India· 6 hours agoMelbourne, Jul 24 (The Conversation) The internet, a vast and indispensable resource for modern...
Budget 2024 Corporate Reactions Live Updates: ‘Well thought,’ reacts Uday Kotak
Livemint· 22 hours agoBudget 2024 Corporate Reactions Live Updates: Finance Minister Nirmala Sitharaman presented her...
The Indian middle class expected more
Hindustan Times· 20 hours agoThe lower end of the middle class has got a tax break with the tax slabs and standard deduction going up in the new tax regime. Standard deduction is up...
Capital gains tax shocker: What should investors do next?
Livemint· 22 hours ago“The rise in long-term capital gains tax is severe, but the prospects of the market remain the same;...
FraudGPT and other malicious AIs are the new frontier of online threats. What can we do?
Hindustan Times· 7 hours agoFraudGPT and other malicious AIs are the new frontier of online threats. What can we do?
Growth@work: The big message from Union budget 2024-25
Livemint· 23 hours agoThe continuity comes from the fact that the government remains on the path of fiscal consolidation...
In Budget 2024, The Lok Sabha Election Effect
NDTV· 20 hours agoThe first budget of the third term of Narendra Modi government bore a clear imprint of the recent Lok Sabha election, in which the BJP failed to gain majority on its own and had to depend on ...
Ayushman Bharat, Medical Infra, Research & Ayush: Budget Booster Shot For Health Initiatives -...
News18· 23 hours agoFrom bolstering insurance, enhancing medical infrastructure to supporting traditional health...
This Canned Fish Is Completely Underrated For Breakfast
Daily Meal· 22 hours agoWeekend mornings can be tough, but this surprisingly delicious canned fish is convenient and packs...
Budget Govt proposes to fully exempt 3 cancer drugs from customs duty
The Week· 23 hours agoThe government proposes to cut customs duties on Trastuzumab Deruxtecan, Osimertinib and Durvalumab from 10 per cent to nil. "To provide relief to cancer patients, I propose to fully exempt ...
